SIRPA and neoplasm: Here the authors show that, in preclinical cancer models, resistance to radiotherapy (RT) observed in wild-type mice is overcome in Sirpα-deficient mice, providing evidences that RT-activated Sirpα-deficient macrophages promote T-cell mediated anti-tumor immune responses.